Onc







Trov was entry to the market knowing it is a hard sell & likely will peak at 250mil but Mag was the drug that was going to be the blockbuster & brand for the Onc franchise then today it was delayed a year with organ failure.
Immunogenis sold Gilead cup fools gold.
I should never came over here from my prev company..... wonder if I can go back if they havent filled my pos?
 






Trov was entry to the market knowing it is a hard sell & likely will peak at 250mil but Mag was the drug that was going to be the blockbuster & brand for the Onc franchise then today it was delayed a year with organ failure.
Immunogenis sold Gilead cup fools gold.
I should never came over here from my prev company..... wonder if I can go back if they havent filled my pos?
Fool
 




































Oncology products are toxic drugs plus we hired a bunch of other companies loosers & retreads ...... if you truly was good then no way you come to unproven Onc at Gilead
LMFAO just reading headlines last 24hrs.
 


















Our Oncology pipeline blew up yesterday.
What morons would rush hiring in 4wks and not wait for FDA decision---
Oh Joanna & Stu
Makes sense now of the poor judgements and leadership with timing.
 










































2nd week on board and I am having 2nd regrets. Our ERD VP & Pres are clueless to what is needed to move a flatline drug that has developed a reputation by patients & now doctors as a dirty drug.
We need to scrap all this BS strategy & marketing stupid as Brand team developed & face head on these nasty side effect issues patients complain about. It will not get better & only worse as more more pts drop therapy so must address it and minimize.
I regret leaving my old co as Gilead Oncology leadership doesnt know what hell doing.
And the President is beyond clueless.... how did she get that high of a position?